Acasti Pharma Inc.

NASDAQ:ACST

3.37 (USD) • At close October 25, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009
Revenue 00000.19600000.0280.2160.450.7070.1270.0290
Cost of Revenue 00.01152.15515.5890.0762.322.333000.060.1880.2620.3970.00500
Gross Profit 0-0.011-52.155-15.5890.12-2.32-2.33300-0.0320.0280.1880.310.0050.0290
Gross Profit Ratio 00000.6120000-1.1620.1310.4170.4390.04210
Reseach & Development Expenses 9.5114.6289.9725.5594.17315.97428.73412.13305.4535.2125.4462.9393.1591.5731.121
General & Administrative Expenses 7.1686.4328.0769.2636.9398.164.2383.11801.6074.7224.8494.18900.8580
Selling & Marketing Expenses 00.3410.136-0.518-1.142-2.6650.66000000000
SG&A 7.1686.186.9539.7816.6558.4644.2383.11801.6074.7224.4484.1893.5140.8580.409
Other Expenses 000.06305.7110000000000.1470.011
Operating Expenses 16.67911.30118.24715.3410.83619.10832.97315.25207.069.9359.8947.1286.5562.4661.538
Operating Income 0-11.312-24.608-15.589-16.419-24.438-33.714-15.2520-7.093-9.906-9.706-6.818-6.551-3.189-1.539
Operating Income Ratio 0000-83.770000-255.254-45.8-21.561-9.638-51.534-109.8140
Total Other Income Expenses Net 0-3.318-45.6314.711-3.259-1.513-4.906-1.402.4318.517-0.730.0870.0120.1130.011
Income Before Tax -12.767-14.685-51.971-10.467-19.678-25.513-38.62-16.6520-6.317-1.323-10.436-6.732-6.5390-1.527
Income Before Tax Ratio 0000-100.3980000-227.328-6.117-23.183-9.517-51.43900
Income Tax Expense 0-1.777-9.542-0.648-0.1270.2475.2410.2910-2.379-8.517-0.246-0.0420.022-0.012-0.03
Net Income -12.767-12.853-42.429-9.819-19.678-25.76-43.862-16.9430-4.661-1.323-10.436-6.732-6.539-3.076-1.508
Net Income Ratio 0000-100.3980000-167.734-6.117-23.183-9.517-51.439-105.9230
EPS -0.79-1.35-5.71-1.6-7.96-14.62-6.46-7.750-20.99-5.98-59.37-44.42-46.68-22.71-33.5
EPS Diluted -0.79-1.35-5.71-1.6-7.96-14.62-6.46-7.750-20.99-5.98-59.37-44.42-46.68-22.71-33.5
EBITDA 0-14.61915.847-19.989-9.792-21.828-30.989-14.0080-5.271-7.97-8.841-6.08-5.858-2.389-1.53
EBITDA Ratio 0000-49.9590000-189.686-36.849-19.64-8.595-46.084-82.2660